natgillin/translations-raw huggingface dataset:
Abnormal hepatic function/liver disorder2 Skin and subcutaneous tissue disorders Rare: 
Abnormalna jetrena funkcija/poremećaj jetre2 Poremećaji kože i potkožnog tkiva
Dose adjustment of the antidiabetic medicinal products may be required (see section 4.4). 
Antidijabetički lijekovi (oralni lijekovi i inzulin) Može biti potrebna prilagodba doze antidijabetičkih lijekova (vidjeti dio 4.4).
No statistically significant difference in the incidence of the primary composite endpoint (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for congestive heart failure) was found [15.7 % in the telmisartan and 17.0 % in the placebo groups with a hazard ratio of 0.92 (95 % CI 0.81 - 1.05, p=0.22)]. 
Nije pronađena statistički značajna razlika u incidenciji primarnog kompozitnog ishoda (kardiovaskularna smrt, nefatalni infarkt miokarda, nefatalni moždani udar ili hospitalizacija zbog kongestivnog zatajenja srca) [15,7% u skupini na telmisartanu i 17,0% u skupini na placebu, s omjerom rizika od 0,92 (95%
Overdose with hydrochlorothiazide is associated with electrolyte depletion (hypokalaemia, hypochloraemia) and hypovolaemia resulting from excessive diuresis. 
Predoziranje hidroklorotiazidom je povezano s deplecijom elektrolita (hipokalemija,
Actelsar HCT 40 mg/12.5 mg tablets Actelsar HCT 80 mg/12.5 mg tablets 
Actelsar HCT 40 mg/12,5 mg tablete Actelsar HCT 80 mg/12,5 mg tablete
Keep this medicine out of the sight and reach of children. 
Kako čuvati Actelsar HCT Lijek čuvajte izvan pogleda i dohvata djece.
Actelsar HCT fixed dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on Actelsar HCT 80 mg/12.5 mg (80 mg telmisartan/12.5 mg hydrochlorothiazide) or adults who have been previously stabilised on telmisartan and hydrochlorothiazide given separately. 
Actelsar HCT je kombinacija fiksne doze (80 mg telmisartana/25 mg hidroklorotiazida), indicirana kod odraslih osoba čiji se krvni tlak ne može adekvatno kontrolirati Actelsarom HTC 80 mg/12,5 mg (80 mg telmisartana/12,5 mg hidroklorotiazida) ili odraslih osoba koje su prethodno stabilizirane zasebnim terapijama telmisartana i hidroklorotiazida.
Investigations Not known: 
Pretrage Nepoznato:
- Medicines that are affected by changes of the blood potassium level such as heart medicines (e.g. digoxin) or medicines to control the rhythm of your heart (e.g. quinidine, disopyramide, amiodarone, sotalol), medicines used for mental disorders (e.g. thioridazine, chlorpromazine, levomepromazine) and other medicines such as certain antibiotics (e.g. sparfloxacine, pentamidine) or certain medicines to treat allergic reactions (e.g. terfenadine). 
- lijekovi na koje utječu promjene vrijednosti kalija u krvi kao što su lijekovi za srce (npr. digoksin) ili lijekovi za kontrolu srčanog ritma (npr. kinidin, disopiramid, amiodaron, sotalol), lijekovi koji se primjenjuju za duševne poremećaje (npr. tioridazin, klorpromazin, levomepromazin) i drugi lijekovi kao što su određeni antibiotici (npr. sparfloksacin, pentamidin) ili određeni lijekovi za liječenje alergijskih reakcija (npr. terfenadin).
Potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes should be co-administered cautiously with Actelsar HCT (see section 4.5). 
Ako se uz Actelsar HCT istodobno primjenjuju diuretici koji štede kalij, nadomjesci kalija, ili zamjene za sol koje sadrže kalij potreban je oprez (vidjeti dio 4.5).
Telmisartan does not show affinity for other receptors, including AT2 and other less characterised AT receptors. 
Telmisartan ne pokazuje afinitet za druge receptore, uključujući
Back pain, muscle spasms, myalgia 
Bol u leđima, mišićni spazmi, mialgija
Telmisartan: The pharmacokinetics of orally administered telmisartan are non-linear over doses from 20-160 mg with greater than proportional increases of plasma concentrations (Cmax and AUC) with increasing doses. 
20-160 mg s više nego proporcionalnim povećanjem koncetracija u plazmi (Cmax i AUC) pri rastućim dozama.
- Actelsar HCT 80 mg/25 mg may be administered once daily in patients whose blood pressure is not adequately controlled by Actelsar HCT 80 mg/12.5 mg or in patients who have been previously stabilised on telmisartan and hydrochlorothiazide given separately. 
- Actelsar HCT 80 mg/12,5 mg se primjenjuje jedanput dnevno kod bolesnika čiji se krvni tlak adekvatno ne kontrolira Actelsarom HTC 80 mg/12,5 mg ili bolesnika koji su prethodno stabilizirani zasebnim terapijama telmisartana i hidroklorotiazida.
White or almost white, 6.55 x 13.6 mm oval-shaped and biconvex tablets marked with “TH” on one side. 
Bijele ili gotovo bijele ovalne bikonveksne tablete, dimenzija 6,55 x 13,6 mm, s oznakom „TH“ s jedne strane.
High HCTZ use (≥50,000 mg cumulative) was associated with an adjusted OR of 1.29 (95% CI: 1.23 
Velika primjena hidroklorotiazida (≥50 000 mg kumulativno) bila je povezana s prilagođenim OR od 1,29 (95% CI: 1,23-1,35) za BCC i 3,98 (95% CI: 3,68-4,31) za SCC.
Summary of the safety profile The most commonly reported adverse reaction is dizziness. 
Najčešća prijavljena nuspojava je omaglica.
Patients were randomized to one of the three following treatment groups: telmisartan 80 mg (n = 8542), ramipril 10 mg (n = 8576), or the combination of telmisartan 80 mg plus ramipril 10 mg (n = 8502), and followed for a mean observation time of 4.5 years. 
(n = 8542), ramipril 10 mg (n = 8576), ili kombinacija telmisartana 80 mg plus ramipril 10 mg
Hyperuricaemia, hyponatraemia 
Hiperuricemija, hiponatremija
- Hyponatraemia and hypochloraemic alkalosis There is no evidence that Actelsar HCT would reduce or prevent diuretic-induced hyponatraemia. 
Ne postoje dokazi da Actelsar HCT smanjuje ili sprječava hiponatremiju induciranu diureticima.
Actelsar HCT 80 mg/25 mg tablets 
Actelsar HCT 80 mg/25 mg tablete
Low platelet count (thrombocytopenia), increase in certain white blood cells (eosinophilia), serious allergic reaction (e.g. hypersensitivity, anaphylactic reaction, drug rash), low blood sugar levels (in diabetic patients), upset stomach, eczema (a skin disorder), arthrosis, inflammation of the tendons, decreased haemoglobin (a blood protein), somnolence. 
Niski broj trombocita (trombocitopenija), porast određenih bijelih krvnih stanica (eozinofilija), ozbiljna alergijska reakcija (npr. preosjetljivost, anafilaktička reakcija, osip uzrokovan uzimanjem lijeka), niske vrijednosti šećera u krvi (kod dijabetičara), nadražaj želuca, ekcem (poremećaj kože),
Based on modest experience in patients with mild to moderate renal impairment (creatinine clearance of 30-60 ml/min, mean about 50 ml/min) no dose adjustment is necessary in patients with decreased renal function. 
Na osnovi skromnog iskustva kod bolesnika s blagim do umjerenim oštećenjem funkcije bubrega (klirens kreatinina od 30-60 ml/min, prosjek oko
Dizziness or drowsiness may occasionally occur when taking Actelsar HCT. 
Kod uzimanja Actelsara HCT mogu se povremeno pojaviti omaglica ili omamljenost.
Actelsar HCT 40 mg/12.5 mg tablets Each tablet contains 40 mg telmisartan and 12.5 mg hydrochlorothiazide. 
Actelsar HCT 40 mg/12,5 mg tablete Jedna tableta sadržava 40 mg telmisartana i 12,5 mg hidroklorotiazida.
Very rare (may affect up to 1 in 10,000 people): Increased pH (disturbed acid-base balance) due to low blood chloride level. 
Povišen pH (poremećena acidobazna ravnoteža) zbog niske razine klorida u krvi.
Actelsar HCT 80 mg/12.5 mg tablets Each tablet contains 80 mg telmisartan and 12.5 mg hydrochlorothiazide. 
Actelsar HCT 80 mg/12,5 mg tablete Jedna tableta sadržava 80 mg telmisartana i 12,5 mg hidroklorotiazida.
Telmisartan is not removed by haemodialysis. 
Liječenje Telmisartan se ne uklanja hemodijalizom.
- Kidney disease or kidney transplant. 
- bolest bubrega ili presađeni bubreg.
- Anti-cholinergic medicines (medicines used to treat a variety of disorders such as gastrointestinal cramps, urinary bladder spasm, asthma, motion sickness, muscular spasms, Parkinson's disease and as an aid to anaesthesia) such as atropine and biperiden. 
- antikolinergički lijekovi (lijekovi koji se primjenjuju u liječenju niza poremećaja poput grčeva probavnog sustava, grča mokraćnog mjehura, astme, bolesti kretanja, grčeva mišića, Parkinsonove bolesti te kao pomoć u anesteziji) kao što su atropin i biperiden. - amantadin (lijek koji se primjenjuje za liječenje Parkinsonove bolesti te se također primjenjuje u liječenju ili prevenciji određenih bolesti uzrokovanih virusima).
These could be symptoms of an increase of pressure in your eye and can happen within hours to weeks of taking Actelsar HCT. 
- djelatna tvar hidroklorotiazid može izazvati neobičnu reakciju koja rezultira smanjenjem vida i boli u očima, koji mogu biti simptomi povišenog tlaka u oku, a do njih može doći unutar nekoliko sati do tjedana primjene Actelsara HCT.
ACE inhibitors, potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium, cyclosporin or other medicinal products such as heparin sodium). 
Lijekovi koji mogu povisiti vrijednosti kalija ili inducirati hiperkalemiju (npr. ACE inhibitori, diuretici koji štede kalij, nadomjesci kalija, zamjenske soli koje sadrže kalij, ciklosporin, ili drugi lijekovi kao što je heparin natrij).
Suspicious skin lesions should be promptly examined potentially including histological examinations of biopsies. 
potencijalno uključujući histološke preglede uzorka dobivenog biopsijom.
In the “Prevention Regimen For Effectively avoiding Second Strokes” (PRoFESS) trial in patients 50 years and older, who recently experienced stroke, an increased incidence of sepsis was noted for telmisartan compared with placebo, 0.70 % vs. 0.49 % [RR 1.43 (95 % confidence interval 1.00-2.06)]; the incidence of fatal sepsis cases was increased for patients taking telmisartan (0.33 %) vs. patients taking placebo (0.16 %) [RR 2.07 (95 % confidence interval 1.14-3.76)]. 
0,49% [RR 1,43 (95% interval pouzdanosti 1,00 - 2,06)]; incidencija slučajeva fatalne sepse je povećana za bolesnike koji su uzimali telmisartan (0,33%) u odnosu na bolesnike na placebu (0,16%) [RR 2,07 (95% interval pouzdanosti 1,14 - 3,76)].
Sialadenitis 
Sijaloadenitis
These medicinal products may potentiate the effect of hydrochlorothiazide on serum potassium (see section 4.4). 
Ovi lijekovi mogu potencirati učinak hidroklorotiazida na serumski kalij
Actelsar HCT 40 mg/12.5 mg tablets 
Actelsar HCT 40 mg/12,5 mg tablete
Musculoskeletal, connective tissue and bone disorders Not known: 
Poremećaji mišićno-koštanog sustava i vezivnog tkiva Nepoznato:
Exacerbation or activation of systemic lupus erythematosus1 Metabolism and nutrition disorders Uncommon: 
Egzacerbacija ili aktivacija sistemskog lupus eritematozusa1
Lithium 
Citokrom
Teл. 
ACE
Side effects of unknown frequency (frequency cannot be estimated from the available data) Inflammation of the salivary gland, skin and lip cancer (Non-melanoma skin cancer), decreases in the number (or even lack) of cells in the blood, including low red and white blood cell count, serious allergic reactions (e.g. hypersensitivity, anaphylactic reaction), decreased or loss of appetite, restlessness, light-headedness, blurred or yellowing of vision, decrease in vision and eye pain (possible signs of acute myopia or acute-angle closure glaucoma), inflammation of blood vessels (vasculitis necrotising), inflamed pancreas, upset stomach, yellowing of the skin or eyes (jaundice), lupus-like syndrome (a condition mimicking a disease called systemic lupus erythematosus where the body's immune system attacks the body); skin disorders such as inflamed blood vessels in the skin, increased sensitivity to sunlight, rash, redness of the skin, blistering of the lips, eyes or mouth, skin peeling , fever (possible signs of erythema multiforme), weakness, kidney inflammation or impaired kidney function, glucose in the urine (glycosuria), fever, impaired electrolyte balance, high blood cholesterol levels, decreased blood volume, increased blood levels of glucose, difficulties in controlling blood/ urine levels of glucose in patients with a diagnosis of diabetes mellitus,or fat in the blood. 
Upala žlijezda slinovnica, rak kože i usana (nemelanomski rak kože), smanjenje broja (ili čak nedostatak) stanica u krvi, uključujući niske vrijednosti crvenih i bijelih krvnih stanica, ozbiljne alergijske reakcije (npr. preosjetljivost, anfilaktička reakcija), smanjen ili gubitak apetita, nemir, ošamućenost, zamućeni vid ili žutilo pred očima, slabljenje vida i bol u oku (mogući znakovi akutne kratkovidnosti ili akutnog glaukoma zatvorenog kuta), upala krvnih žila (nekrotizirajući vaskulitis), upala gušterače (pankreatitis), nadražen želudac, žutilo kože ili bjeloočnica (žutica), sindrom sličan lupusu (stanje koje oponaša bolest koja se naziva sistemski lupus eritematozus pri kojem imunološki sustav tijela napada tijelo), poremećaji kože kao što je upala krvnih žila kože, povećana osjetljivost na sunčevu svjetlost, osip, crvenilo kože, mjehurići na usnicama, očima ili u ustima, ljuštenje kože, vrućica (mogući znakovi multiformnog eritema), slabost, upala bubrega ili oštećenje bubrežne funkcije, glukoza u urinu (glikozurija), vrućica, poremećena ravnoteža elektrolita, visoke vrijednosti kolesterola u krvi, smanjeni volumen krvi, povišene vrijednosti glukoze u krvi, poteškoće s kontrolom razine glukoze u krvi/urinu u bolesnika s dijagnozom šećerne bolesti,ili masnoća u krvi.
Side effects of unknown frequency (frequency cannot be estimated from the available data) Inflammation of the salivary gland, skin and lip cancer (Non-melanoma skin cancer), decreases in the number (or even lack) of cells in the blood, including low red and white blood cell count, serious allergic reactions (e.g. hypersensitivity, anaphylactic reaction), decreased or loss of appetite, restlessness, light-headedness, blurred or yellowing of vision, decrease in vision and eye pain (possible signs of acute myopia or acute-angle closure glaucoma), inflammation of blood vessels (vasculitis necrotising), inflamed pancreas, upset stomach, yellowing of the skin or eyes (jaundice), lupus-like syndrome (a condition mimicking a disease called systemic lupus erythematosus where the body's immune system attacks the body); skin disorders such as inflamed blood vessels in the skin, increased sensitivity to sunlight, rash, redness of the skin, blistering of the lips, eyes or mouth, skin peeling , fever (possible signs of erythema multiforme), weakness, kidney inflammation or impaired kidney function, glucose in the urine (glycosuria), fever, impaired electrolyte balance, high blood cholesterol levels, decreased blood volume, increased blood levels of glucose, difficulties in controlling blood/ urine levels of glucose in patients with a diagnosis of diabetes mellitus, or fat in the blood. 
Upala žlijezda slinovnica, rak kože i usana (nemelanomski rak kože), smanjenje broja (ili čak nedostatak) stanica u krvi, uključujući niske vrijednosti crvenih i bijelih krvnih stanica, ozbiljne alergijske reakcije (npr. preosjetljivost, anfilaktička reakcija), smanjen ili gubitak apetita, nemir, ošamućenost, zamućeni vid ili žutilo pred očima, slabljenje vida i bol u oku (mogući znakovi akutne kratkovidnosti ili akutnog glaukoma zatvorenog kuta), upala krvnih žila (nekrotizirajući vaskulitis), upala gušterače (pankreatitis), nadražen želudac, žutilo kože ili bjeloočnica (žutica), sindrom sličan lupusu (stanje koje oponaša bolest koja se naziva sistemski lupus eritematozus pri kojem imunološki sustav tijela napada tijelo), poremećaji kože kao što je upala krvnih žila kože, povećana osjetljivost na sunčevu svjetlost, osip, crvenilo kože, mjehurići na usnicama, očima ili u ustima, ljuštenje kože, vrućica (mogući znakovi multiformnog eritema), slabost, upala bubrega ili oštećenje bubrežne funkcije, glukoza u urinu (glikozurija), vrućica, poremećena ravnoteža elektrolita, visoke vrijednosti kolesterola u krvi, smanjeni volumen krvi, povišene vrijednosti glukoze u krvi, poteškoće s kontrolom razine glukoze u krvi/urinu u bolesnika s dijagnozom šećerne bolesti, ili masnoća u krvi.
- Heart trouble. 
- poteškoće sa srcem. - šećerna bolest.
There is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure). 
Dvostruka blokada sustava renin-angiotenzin-aldosteron (RAAS) Postoje dokazi da istodobna primjena ACE inhibitora, blokatora angiotenzin II receptora ili aliskirena povećava rizik od hipotenzije, hiperkalemije i smanjene bubrežne funkcije (uključujući akutno zatajenje bubrega).
Nervous system disorders Rare: 
Poremećaji živčanog sustava Često:
14 tablets 28 tablets 30 tablets 56 tablets 84 tablets 90 tablets 98 tablets 
14 tableta 28 tableta 30 tableta 56 tableta 84 tableta 90 tableta 98 tableta
Thiazide diuretic associated azotaemia may occur in patients with impaired renal function. 
Kod bolesnika s oštećenom bubrežnom funkcijom može doći do pojave azotemije povezane s tiazidskim diuretikom.
ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints) was a study designed to test the benefit of adding aliskiren to a standard therapy of an ACE-inhibitor or an angiotensin II receptor blocker in patients with type 2 diabetes mellitus and chronic kidney disease, cardiovascular disease, or both. 
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints) je bilo ispitivanje osmišljeno za testiranje koristi dodavanja aliskirena standardnoj terapiji s
Renal impairment and kidney transplantation 
Poremećaji bubrega i mokraćnog sustava
The overall incidence and pattern of adverse reactions reported with telmisartan/hydrochlorothiazide 80 mg/25 mg was comparable with telmisartan/hydrochlorothiazide 80 mg/12.5 mg. A doserelationship of adverse reaction was not established and they showed no correlation with gender, age or race of the patients. 
Ukupna incidencija i obrazac nuspojava prijavljenih uz telmisartan/hidroklportiazid 80 mg/25 mg usporedivi su s onima telmisartana/hidroklorotiazida 80 mg/12,5 mg.
Actelsar HCT 80 mg/25 mg tablets telmisartan/hydrochlorothiazide 
Actelsar HCT 80 mg/25 mg tablete telmisartan/hidroklorotiazid
Stomach discomfort Skin and subcutaneous tissue disorders Rare: 
Poremećaji mišićno-koštanog sustava i vezivnog tkiva Rijetko:
28 tablets 56 tablets 84 tablets 90 tablets 98 tablets 
28 tableta 56 tableta 84 tableta 90 tableta 98 tableta
Package leaflet: Information for the user Actelsar HCT 80 mg/25 mg tablets telmisartan/hydrochlorothiazide 
Uputa o lijeku: Informacije za korisnika Actelsar HCT 80 mg/25 mg tablete telmisartan/hidroklorotiazid
Aplastic anaemia, haemolytic anaemia, bone marrow failure, leukopenia, neutropenia, agranulocytosis, 
Aplastična anemija, hemolitička anemija, zatajenje koštane srži,
Package leaflet: Information for the user Actelsar HCT 40 mg/12.5 mg tablets telmisartan/hydrochlorothiazide 
Uputa o lijeku: Informacije za korisnika Actelsar HCT 40 mg/12,5 mg tablete telmisartan/hidroklorotiazid
14 tablets 28 tablets 56 tablets 84 tablets 90 tablets 98 tablets 
14 tableta 28 tableta 56 tableta 84 tableta 90 tableta 98 tableta
Antidiabetic medicinal products (oral agents and insulin) 
Nesteroidni protuupalni lijekovi (NSAIL-i)
Actelsar HCT 80 mg/12.5 mg tablets White or almost white, 9.0 x 17.0 mm capsule-shaped tablets marked with “TH 12.5” on both sides. 
Bijele ili gotovo bijele tablete u obliku kapsula, dimenzija 9,0 x 17,0 mm, s obje strane označene oznakom „TH 12.5“.
Reykjavíkurvegur 78, 220 Hafnarfjörður, Iceland 
Actavis hf. Reykjavíkurvegur 78, 220 Hafnarfjörður, Island
Package leaflet: Information for the user Actelsar HCT 80 mg/12.5 mg tablets telmisartan/hydrochlorothiazide 
Uputa o lijeku: Informacije za korisnika Actelsar HCT 80 mg/12,5 mg tablete telmisartan/hidroklorotiazid
Actelsar HCT 80 mg/12.5 mg tablets telmisartan/hydrochlorothiazide 
Actelsar HCT 80 mg/12,5 mg tablete telmisartan/hidroklorotiazid
Diabetes mellitus inadequate control Metabolism and nutrition disorders Common: 
Poremećaji metabolizma i prehrane Često:
How to store Actelsar HCT 
Moguće nuspojave Kako čuvati Actelsar HCT
Actelsar HCT 40 mg/12.5 mg tablets telmisartan/hydrochlorothiazide 
Actelsar HCT 40 mg/12,5 mg tablete telmisartan/hidroklorotiazid
- Actelsar HCT 40 mg/12.5 mg may be administered once daily in patients whose blood pressure is not adequately controlled by telmisartan 40 mg - Actelsar HCT 80 mg/12.5 mg may be administered once daily in patients whose blood pressure is not adequately controlled by telmisartan 80 mg 
Actelsar HCT 40 mg/12,5 mg se primjenjuje jedanput dnevno kod bolesnika čiji se krvni tlak adekvatno ne kontrolira telmisartanom 40 mg.
- Renal artery stenosis (narrowing of the blood vessels to one or both kidneys). 
- stenoza bubrežne arterije (sužavanje krvnih žila koje vode u jedan ili oba bubrega). - bolest jetre.
Al/Al blister: 14, 28, 30, 56, 84, 90 and 98 tablets Al/PVC/PVDC blister: 28, 56, 84, 90 and 98 tablets Tablet container: 30, 90 and 250 tablets 
Al/Al blister: 14, 28, 30, 56, 84, 90 i 98 tableta Al/PVC/PVDC blister: 28, 56, 84, 90 i 98 tableta Spremnik s tabletama: 30, 90 i 250 tableta
Al/Al blister packs: 14, 30, 28, 56, 84, 90 and 98 tablets Al/PVC/PVDC blister packs: 14, 28, 56, 84, 90 and 98 tablets Tablet containers: 30, 90 and 250 tablets 
Al/Al blister pakiranja: 14, 28, 30, 56, 84, 90 i 98 tableta Al/PVC/PVDC blister pakiranja: 14, 28, 56, 84, 90 i 98 tableta Spremnici s tabletama: 30, 90 i 250 tableta
Al/Al blister packs: 14, 28, 30, 56, 84, 90 and 98 tablets Al/PVC/PVDC blister packs: 28, 56, 84, 90 and 98 tablets Tablet containers: 30, 90 and 250 tablets 
Al/Al blister pakiranja: 14, 28, 30, 56, 84, 90 i 98 tableta Al/PVC/PVDC blister pakiranja: 28, 56, 84, 90 i 98 tableta Spremnici s tabletama: 30, 90 i 250 tableta
Eczema, drug eruption, toxic skin eruption Musculoskeletal, connective tissue and bone disorders Rare: 
hiperhidroza, urtikarija Poremećaji mišićno-koštanog sustava i vezivnog tkiva
Talk to your doctor before taking Actelsar HCT, if you are taking: - any of the following medicines used to treat high blood pressure: an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems. 
ACE inhibitor (primjerice enalapril, lisinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću.
How to store Actelsar HCT Contents of the pack and other information 
Sadržaj pakiranja i druge informacije
Actelsar HCT 40 mg/12.5 mg tablets are white or almost white, 6.55 x 13.6 mm oval-shaped and biconvex tablets marked with “TH” on one side. 
Actelsar HCT 40 mg/12,5 mg tablete su bijele ili gotovo bijele ovalne bikonveksne tablete, dimenzija
Nervous system disorder Rare: 
Poremećaji probavnog sustava Manje često:
This can lead to permanent vision impairment, if not treated. 
Ako se ne liječe, mogu dovesti do trajnog oštećenja vida.
Actelsar HCT 80 mg/12.5 mg tablets are white or almost white, 9.0 x 17.0 mm capsule-shaped tablets marked with “TH 12.5” on both sides. 
Actelsar HCT 80 mg/12,5 mg tablete su bijele ili gotovo bijele tablete u obliku kapsula, dimenzija